Home
Conditions
Disease Attributes

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,705 public trials 3,134 recruiting studies

Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis

NCT04996628

Conditions: Chronic Disease, Chronic Pain, Chronic Pancreatitis, +10 more
Locations: Indiana University Medical Center Indianapolis, Indiana, United States

Johns Hopkins Medical Institutions Baltimore, Maryland, United States

University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

NCT05641259

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations: The First Affiliated Hospital of Nanchang University Nanchang, China

First Affiliated Hospital of Soochow University Suzhou, China

Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou, China

View Trial Details

Recruiting

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

NCT05726526

Conditions: Chronic Disease, Chronic Kidney Disease Stage 5, Disease Attributes, +12 more
Locations: St. Boniface Hospital Winnipeg, Manitoba, Canada

Chronic Disease Innovation Centre, Seven Oaks Hospital Winnipeg, Manitoba, Canada

Health Sciences Centre Winnipeg, Manitoba, Canada

London Health Sciences Centre London, Ontario, Canada

View Trial Details

Recruiting

Continuous Versus High Intensity Interval Exercise in Chronic Obstructive Pulmonary Disease

NCT07707271

Conditions: COPD, Chronic Disease, Disease Attributes, +6 more
Locations: George Papanikolaou General Hoapital of Thessaloniki Thessaloniki, Exohi, Greece

View Trial Details

Recruiting

Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

NCT07454837

Conditions: Chronic Disease, Chronic Hepatitis D, Digestive System Diseases, +12 more
Locations: Medical University of Graz Graz, Austria

Medizinische Universitat Innsbruck Innsbruck, Austria

Fakultni Nemocnice Brno (University Hospital Brno) Brno, Czechia

Klin Med Ltd. (KLIN MED s.r.o.) Prague, Czechia

View all 44 locations

View Trial Details

Recruiting

Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

NCT02450851

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Genetic Disease, +5 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

HudsonAlpha Institute for Biotechnology, Inc. Huntsville, Alabama, United States

University of California, Los Angeles Los Angeles, California, United States

University of California, Irvine Medical Center Orange, California, United States

View all 33 locations

View Trial Details

Recruiting

Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia

NCT05915663

Conditions: Cross Infection, Disease Attributes, Healthcare-Associated Pneumonia, +10 more
Locations: Centre Hospitalier Du Mans Le Mans, France

CHU Angers Angers, France

CH Cholet Cholet, France

CHU Grenoble Grenoble, France

View all 16 locations

View Trial Details

Recruiting

Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2

NCT07074418

Conditions: Chronic Disease, Chronic Kidney Diseases, Disease Attributes, +10 more
Locations: CHU Nice - Hôpital Pasteur 2 Nice, Alpes-Maritimes, France

View Trial Details

Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07032662

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Site Number - 1612 Tucson, Arizona, United States

Site Number - 1618 Carlsbad, California, United States

Site Number - 1619 Orange, California, United States

Site Number - 1607 Rancho Mirage, California, United States

View all 142 locations

View Trial Details

Recruiting

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

NCT01356290

Conditions: ATRT Recurrent, Disease Attributes, Ependymoma, +16 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

Dana-Farber Cancer Institute and Boston Children's Hospital Boston, Massachusetts, United States

Helen DeVos Children's Hospital Grand Rapids, Michigan, United States

Dell Children's Medical Group SFC-HEM/ONC Austin, Texas, United States

View all 22 locations

View Trial Details

Disease Attributes

Disease Attributes trial results

Related conditions